These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1151137)

  • 1. Urinary iron in patients with sickle cell anamia.
    Washington R; Boggs DR
    J Lab Clin Med; 1975 Jul; 86(1):17-23. PubMed ID: 1151137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary iron excretion and renal metabolism of hemoglobin in hemolytic diseases.
    Sears DA; Anderson PR; Foy AL; Williams HL; Crosby WH
    Blood; 1966 Nov; 28(5):708-25. PubMed ID: 5924365
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron burden in sickle cell anemia.
    O'Brien RT
    J Pediatr; 1978 Apr; 92(4):579-82. PubMed ID: 633016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traumatic hemolysis with iron deficiency anemia in patients with aortic valve lesions.
    Eyster E; Mayer K; McKenzie S
    Ann Intern Med; 1968 May; 68(5):995-1004. PubMed ID: 5646831
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease.
    Collins AF; Fassos FF; Stobie S; Lewis N; Shaw D; Fry M; Templeton DM; McClelland RA; Koren G; Olivieri NF
    Blood; 1994 Apr; 83(8):2329-33. PubMed ID: 8161801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria in sickle cell disease.
    Aoki RY; Saad ST
    Braz J Med Biol Res; 1990; 23(11):1103-6. PubMed ID: 2133017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.
    Hussain MA; Green N; Flynn DM; Hussein S; Hoffbrand AV
    Lancet; 1976 Dec; 2(7998):1278-80. PubMed ID: 63749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary creatine: biochemical indicator for evaluation of sickle cell crises.
    Beyer C; Statius van Eps LW; Kastelein JJ; Brandjes DP; Mairuhu WM; van den Ende A
    Clin Chem; 1985 Jul; 31(7):1232-4. PubMed ID: 4006197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal involvement in sickle cell-beta thalassemia.
    Kontessis P; Mayopoulou-Symvoulidis D; Symvoulidis A; Kontopoulou-Griva I
    Nephron; 1992; 61(1):10-5. PubMed ID: 1382236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of iron in response to deferoxamine in sickle cell anemia.
    Cohen A; Schwartz E
    J Pediatr; 1978 Apr; 92(4):659-62. PubMed ID: 633013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in sickle cell trait and disease: an electrophoretic analysis.
    Lonsdorfer A; Comoe L; Yapo AE; Lonsdorfer J
    Clin Chim Acta; 1989 May; 181(3):239-47. PubMed ID: 2758678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients.
    Hoffbrand AV; AL-Refaie F; Davis B; Siritanakatkul N; Jackson BF; Cochrane J; Prescott E; Wonke B
    Blood; 1998 Jan; 91(1):295-300. PubMed ID: 9414297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinuria in children with sickle cell disease.
    Marsenic O; Couloures KG; Wiley JM
    Nephrol Dial Transplant; 2008 Feb; 23(2):715-20. PubMed ID: 18065783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major.
    Wahidiyat PA; Wijaya E; Soedjatmiko S; Timan IS; Berdoukas V; Yosia M
    Blood Cells Mol Dis; 2019 Jul; 77():67-71. PubMed ID: 30978615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sodium intake on zinc excretion in patients with sickle cell anemia.
    Matustik MC; Chausmer AB; Meyer WJ
    J Am Coll Nutr; 1982; 1(4):331-6. PubMed ID: 7185865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary iron excretion in thalassaemia after desferrioxamine administration.
    Seshadri R; Colebatch JH; Fisher R
    Arch Dis Child; 1974 Mar; 49(3):195-9. PubMed ID: 4825624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary iron excretion in valvular heart disease and after heart valve replacement.
    Roeser HP; Powell LW
    Blood; 1970 Dec; 36(6):785-92. PubMed ID: 5485122
    [No Abstract]   [Full Text] [Related]  

  • 20. Kidney iron deposition by R2* is associated with haemolysis and urinary iron.
    Denton CC; Detterich JA; Coates TD; Wood JC
    Br J Haematol; 2021 May; 193(3):633-636. PubMed ID: 33216350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.